Bio-Rad Laboratories (BIO) Depreciation & Amortization (CF) (2009 - 2017)
Bio-Rad Laboratories (BIO) posted quarterly Depreciation & Amortization (CF) of $35.4 million for Q3 2017, down 8.12% year-over-year from $38.5 million in Q3 2016, and down 4.49% quarter-over-quarter from $37.0 million in Q2 2017.
Bio-Rad Laboratories (BIO) Depreciation & Amortization (CF) (2009 - 2017) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Depreciation & Amortization (CF) for 9 consecutive years, with $35.4 million the latest figure, recorded in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 355.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 42.70 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 68.20 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 750.89 Mn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 123.80 Mn |
| 10 | Bio-Rad Laboratories | 10.23 Bn | 8.61 Bn | 345.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2017 | 35.36 Mn |
| Sep 30, 2017 | 35.36 Mn |
| Jun 30, 2017 | 37.03 Mn |
| Jun 30, 2017 | 37.03 Mn |
| Mar 31, 2017 | 33.66 Mn |
| Mar 31, 2017 | 33.66 Mn |
| Sep 30, 2016 | 38.49 Mn |
| Sep 30, 2016 | 38.49 Mn |
| Jun 30, 2016 | 37.58 Mn |
| Jun 30, 2016 | 37.58 Mn |
| Mar 31, 2016 | 34.09 Mn |
| Mar 31, 2016 | 34.09 Mn |
| Sep 30, 2015 | 33.56 Mn |
| Sep 30, 2015 | 33.56 Mn |
| Jun 30, 2015 | 32.13 Mn |
| Jun 30, 2015 | 32.13 Mn |
| Mar 31, 2015 | 32.28 Mn |
| Mar 31, 2015 | 32.28 Mn |
| Sep 30, 2014 | 37.12 Mn |
| Sep 30, 2014 | 37.12 Mn |